Applied Dna Scns (APDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
Sales | 4,408 | 5,263 | 3,559 | 4,296 | 6,147 |
Cost of Goods | 2,600 | 2,885 | 3,143 | 3,257 | 3,659 |
Gross Profit | 1,807 | 2,378 | 417 | 1,039 | 2,489 |
Operating Expenses | 5,112 | 4,482 | 4,812 | 4,153 | 5,302 |
Operating Income | -2,704 | -1,219 | -4,252 | -2,857 | -2,154 |
Other Income | 3,255 | -2,625 | 3,588 | 1,732 | 394 |
Pre-tax Income | 551 | -3,844 | -665 | -1,125 | -1,760 |
Net Income Continuous | 551 | -3,844 | -665 | -1,125 | -1,760 |
Minority Interests | -37 | -1 | 0 | -1 | -1 |
Net Income | $588 | $-3,843 | $-665 | $-1,124 | $-1,759 |
EPS Basic Total Ops | 0.91 | -6.00 | 1.20 | -2.60 | -4.60 |
EPS Basic Continuous Ops | 0.85 | -5.96 | 1.03 | -2.50 | -4.36 |
EPS Diluted Total Ops | 0.91 | -6.00 | 1.20 | -2.60 | -4.60 |
EPS Diluted Continuous Ops | 0.85 | -5.96 | 1.03 | -2.50 | -4.36 |
EPS Diluted Before Non-Recurring Items | -4.00 | -2.80 | N/A | N/A | N/A |
EBITDA(a) | $-2,360 | $-880 | $-3,925 | $-2,536 | $-1,833 |